Table 3.

Mean changes in body weight (kg) from TDR visit 1 (week 0) in those continuing in TDR

Week	All participants (n = 143)			Discontinued antihypertensive medications (n = 69)
	n		p value	n		p value
1	139	−3.01 ± 1.58	<0.0001	69	−3.04 ± 1.56	<0.0001
3	138	−5.71 ± 2.48	<0.0001	69	−5.97 ± 2.44	<0.0001
5	136	−7.92 ± 3.19	<0.0001	69	−8.19 ± 3.26	<0.0001
7	132	−9.98 ± 4.27	<0.0001	69	−10.13 ± 3.96	<0.0001
9	123	−11.46 ± 4.60	<0.0001	65	−12.02 ± 4.73	<0.0001
11	107	−12.80 ± 5.45	<0.0001	58	−13.08 ± 5.76	<0.0001
13	86	−12.78 ± 5.88	<0.0001	48	−13.11 ± 6.87	<0.0001
15	70	−13.09 ± 5.80	<0.0001	40	−13.28 ± 6.47	<0.0001
17	49	−12.17 ± 4.97	<0.0001	29	−12.20 ± 4.96	<0.0001
19	22	−11.02 ± 4.80	<0.0001	12	−11.40 ± 4.90	<0.0001
20	4	−6.57 ± 4.51	0.062	3	−6.27 ± 5.48	0.186

Data presented as mean ± SD

Numbers decline as participants move to the FR phase or withdraw